Introduction
============

Branch retinal vein occlusion (BRVO) is the second most common retinal vascular disorder after diabetic retinopathy.[@b1-opth-7-237],[@b2-opth-7-237] Acute BRVO is characterized by fame-shaped retinal hemorrhage, cotton-wool spots, and venous dilation in the affected retina.[@b2-opth-7-237],[@b3-opth-7-237] Increased intravascular pressure with reduced blood flow in the macular capillaries and the production of vascular endothelial growth factor from the ischemic retina lead to dysfunction of the endothelial blood-retinal barrier and the result is increased leakage in the macular area.[@b4-opth-7-237] When the fovea is involved in BRVO, visual acuity is often decreased due to macular edema.[@b5-opth-7-237],[@b6-opth-7-237] In addition, it is reported that macular edema associated with BRVO is often accompanied by serous retinal detachment (SRD) beneath the fovea and extensive leakage from macular capillaries may migrate to the subretinal space.[@b7-opth-7-237]--[@b11-opth-7-237]

Patients with BRVO are often asymptomatic when the macular capillaries are not affected. However, extramacular BRVO occasionally causes visual disturbances due to macular complications, such as macular edema or foveal SRD.12--14 Previously, Wise and Wangvivat15 reported that the macula experiences an exaggerated SRD in some retinal disorders and Finkelstein and Patz16 reported the distant effects of peripheral BRVO on the macula. However, the reason why SRD in eyes with extramacular BRVO occurs preferentially beneath the fovea remains unknown. In the present study, we examined sequential sections obtained from spectral-domain optical coherence tomography (OCT) from eyes with extramacular BRVO and elucidated the pathophysiology of macular complications associated with extramacular BRVO.

Patients and methods
====================

We retrospectively reviewed the medical records of nine patients (nine eyes; six men and three women, ranging in age from 53 to 88 years \[average, 65.7 ± 12.0 years\] \[[Table 1](#t1-opth-7-237){ref-type="table"}\]) with extramacular BRVO with macular complications, who had been examined at the Department of Ophthalmology, Kyoto University Hospital, from October 2007 to November 2011. The current study was approved by the Institutional Review Board at Kyoto University Graduate School of Medicine and adhered to the tenets of the Declaration of Helsinki.

On their initial visits, patients underwent comprehensive ophthalmologic examinations, including measurement of best-corrected visual acuity using the Landolt chart, determination of intraocular pressure, indirect ophthalmoscopy, slit-lamp biomicroscopy with a contact lens, and spectral-domain OCT (Spectralis HRA + OCT, Heidelberg Engineering, Heidelberg, Germany; 3D-OCT 1000, Topcon, Tokyo, Japan). The macular region was examined in detail with consecutive thin sections of OCT in order to evaluate morphologic changes in the macular area. Vertical and horizontal line scans, which were centered on the fovea, were also obtained. Using these OCT images, we performed three measurements: total retinal thickness in the fovea, thickness of the neurosensory retina in the fovea, and thickness of the SRD in the fovea.

Results
=======

In the current study, the medical records of nine eyes from nine patients with extramacular BRVO were reviewed. The duration of symptoms ranged from 2 days to 1 year (median, 1 month). Extramacular BRVO was observed in the inferior area in three eyes, in the superior area in five eyes, and in the nasal area in one eye. The fovea was not directly affected by retinal hemorrhage, macular edema, or ischemia as a result of the BRVO. However, visual acuity was moderately disturbed (median, 0.6; range, 0.2--0.9 according to the Landolt chart). Total retinal thickness in the fovea ranged from 254 μm to 529 μm (mean ± standard deviation; 413 ± 80 μm). In all eyes, OCT examinations showed SRD under the fovea, which was thickest beneath the fovea, ranging from 92 μm to 364 μm (mean ± standard deviation; 234 ± 92 μm). Most eyes retained the preserved convex of the fovea with a mean foveal thickness in the neurosensory retina of 179 ± 68 μm.

Of these nine eyes, one showed extensive subfoveal SRD that was connected to the area affected by BRVO through the subretinal space. In the remaining eight eyes, OCT showed focal foveal SRD without subretinal connections to the area affected by BRVO. However, all of the eyes showed marked retinal swelling in the outer retina, particularly in the outer plexiform layer ([Figure 1](#f1-opth-7-237){ref-type="fig"}). Six eyes showed numerous cystoid spaces in the outer plexiform layer. In two of the eyes, detailed OCT examinations showed a small break on the external surface of the neurosensory retina that connects the swollen outer retina with the underlying SRD ([Figure 2](#f2-opth-7-237){ref-type="fig"}). All eyes showed hyperreflective foci in the outer retina, most frequently along the inner boundary of the outer plexiform layer and external limiting membrane ([Figure 3](#f3-opth-7-237){ref-type="fig"}). In the patients in the present study, none of the eyes showed vitreomacular traction in the macular area.

SRD regressed spontaneously in three of the eyes, and six of the eyes showed SRD regression immediately after the application of focal laser photocoagulation for BRVO ([Figure 3](#f3-opth-7-237){ref-type="fig"}). The mean follow-up duration was 20.2 ± 18.3 months. At the final visit, visual acuity ranged from 0.2 to 1.5 (median, 0.65), as measured by the Landolt chart.

Discussion
==========

In the current study, nine eyes with extramacular BRVO showed retinal swelling in the macular area with foveal SRD. Macular swelling was predominantly observed in the outer plexiform layer while the inner layer of the retina often retained relatively normal physiologic structure. Using timedomain OCT, Takahashi et al[@b14-opth-7-237] previously reported four cases of foveal SRD associated with extramacular BRVO. The authors speculated that the leakage from the extramacular BRVO traveled to the macula through the subretinal space and formed the SRD beneath the fovea. In the current study, however, we could not detect any subretinal connections between the area affected by BRVO and the foveal SRD, even with sequential thin sectioning using spectral-domain OCT.

The eyes from two of the patients in the study showed a small break on the external surface of the detached neurosensory retina near the fovea. In these eyes, the break seemed to allow fluid that had accumulated within the outer retina to flow into the subretinal space. Recent advances in OCT resolution and contrast have facilitated the detection of breaks on the external surface of the neurosensory retina in eyes with diabetic macular edema,[@b17-opth-7-237] retinal arterial macroaneurysms,[@b18-opth-7-237] and retinal vein occlusions.[@b10-opth-7-237] Although it may be an uncommon feature associated with SRD, we could not detect any apparent breaks on the external surface of the retina in the remaining eyes. Small breaks on the external surface of the retina may be one possible mechanism for causing focal SRD beneath the fovea. Simple diffusion of intraretinal fluid into the subretinal space may represent a more common cause of foveal SRD associated with extramacular BRVO.[@b19-opth-7-237]

It is not known why focal SRD associated with extramacular BRVO invariably occurs beneath the fovea. Previously, Taki et al[@b20-opth-7-237] reported a case of macular edema caused by an extramacular BRVO that improved after vitrectomy. However, none of the eyes from the patients reviewed in this study showed vitreomacular traction in the macular area. Tsujikawa et al[@b10-opth-7-237] reported that Müller cell cone traction plays a role in the formation of small pointed foveal SRD in eyes with retinal vein occlusion. They reported that small pointed SRD extends to become dome-shaped SRD, which resembles the SRD observed in our study patients. Müller cell cones, which are believed to serve as plugs that bind the photoreceptor cells to the foveola,[@b21-opth-7-237] extend outward and form the internal limiting membrane at the foveal area.[@b22-opth-7-237],[@b23-opth-7-237] In eyes with extramacular BRVO, leakage from the affected retinal capillaries travels preferentially through the outer plexiform layer and causes retinal edema mainly within Henle's layer. At the fovea, however, Müller cell cones serve to maintain the integrity of the foveal structure and consequently cause traction with the inner and outer segments of the foveal photoreceptors, which results in foveal SRD. In the current study, none of the records reviewed reported focal SRD outside the fovea. Because patients may not have had symptoms arising from the focal SRD formed outside the fovea, we cannot deny the possibility that some patients had this type of SRD.

Of the nine eyes in this study, two had a final visual acuity of less than 0.5. Visual prognosis of eyes with extramacular BRVO is better than those with macular BRVO, even if they have SRD under the fovea. In the current study, the mean total retinal thickness in the fovea was 413 ± 80 μm. However, most of the patients reviewed had relatively normal neurosensory retinal thickness in the fovea (mean ± standard deviation; 179 ± 68 μm). The formation of SRD under the fovea may contribute to retaining the integrity of the foveal structure. Unless SRD develops under the fovea, fluid extending into the fovea may form large foveal cystoid spaces, leading to severe visual dysfunction.[@b24-opth-7-237] SRD may occasionally regress spontaneously, but focal laser photocoagulation often results in immediate regression. In the current study, all eyes showed hyperreflective foci in the outer retina, most frequently along the inner boundary of the outer plexiform layer and external limiting membrane. It is reported that hyperreflective foci are mainly small lipid exudates left after the absorption of intraretinal fluid.[@b25-opth-7-237],[@b26-opth-7-237] Foveal accumulation of the hard exudate may cause destruction of the foveal structure and lead to poor visual prognosis.[@b13-opth-7-237]

Limitations of the current study include its retrospective nature and small sample size. In addition, when extramacular BRVO causes no macular complications, patients rarely present ocular symptoms. Thus, it is difficult to estimate the risk of macular complications when BRVO occurs outside the vascular arcade. Furthermore, in all of our patients, leakage from the BRVO extended towards the macula, even if BRVO occurred in the inferior quadrant. The reason for this preferential fluid extension is unclear. Therefore, although the leakage from extramacular BRVO may extend in various directions, we only reviewed cases with extramacular BRVO that had macular complications.
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![Extramacular branch retinal vein occlusion (BRVO) with serous retinal detachment beneath the fovea. (**A**) Fundus photograph shows a fame-shaped hemorrhage out of the vascular arcade (patient 7). Visual acuity was measured as 0.8 using the Landolt chart. (**B**) Fluorescein angiogram shows no leakage in the macular area. (**C**--**H**) Sectional images along the arrows c--h in the fundus photograph were obtained using optical coherence tomography. Focal serous retinal detachment is seen under the fovea (asterisk). No subretinal connection is seen between the area affected with extramacular BRVO and the serous detachment. Marked retinal swelling in the outer retina, especially in the outer plexiform layer, is seen between the fovea and the area affected with BRVO. Numerous cystoid spaces are seen in the outer plexiform layer (arrow).](opth-7-237Fig1){#f1-opth-7-237}

![A small break on the external boundary of the retina in an eye with serous retinal detachment associated with extramacular branch retinal vein occlusion. (**A**) Fundus photograph shows a fame-shaped hemorrhage out of the vascular arcade (patient 1). Visual acuity was measured as 0.5 using the Landolt chart. (**B**) Fluorescein angiogram shows no leakage in the macular area. (**C**) Microperimetry shows decreased retinal function in the macular area involving the fovea. Vertical (**D**) and horizontal (**E**) sectional images were obtained with optical coherence tomography along the white arrows. Extensive retinal edema and numerous hyperreflective foci are seen predominantly in the outer plexiform layer with a focal serous detachment beneath the fovea. A small break is seen on the external boundary of the detached retina. (**F**) Magnified image depicted in [Figure 2E](#f2-opth-7-237){ref-type="fig"} more clearly shows the aforementioned break (arrow). The swollen outer retina appears to be connected with the subretinal space.](opth-7-237Fig2){#f2-opth-7-237}

![regression of serous retinal detachment by focal laser photocoagulation to extramacular branch retinal vein occlusion (BRVO). (**A**) Fundus photograph shows residual retinal hemorrhage and shut vessels inferiorly out of the vascular arcade (patient 3). Hard exudate deposition is seen around the fovea. (**B**) Horizontal sectional image was obtained using optical coherence tomography along the white arrow. Extensive retinal edema is seen in the outer plexiform layer with a focal serous detachment beneath the fovea. Hyperreflective foci are predominantly seen along the inner boundary of the outer plexiform layer and external limiting membrane. Visual acuity was measured as 0.7 using the Landolt chart. Focal laser photocoagulation was applied to the area affected with extramacular BrVO. (**C**) Three weeks after treatment, the hard exudate around the fovea seemed to increase. (**D**) Horizontal sectional image along the white arrow shows a decrease in serous retinal detachment. (**E**) One year after the treatment, the hard exudate disappeared completely. (**F**) Horizontal sectional image along the white arrow shows a complete absorbance of macular edema and serous retinal detachment. Final visual acuity was measured as 0.9 using the Landolt chart.](opth-7-237Fig3){#f3-opth-7-237}

###### 

Ocular characteristics of eyes with distant branch retinal vein occlusion

  Patient   Age (years)/ gender/ eye   Location of BRVO   Initial VA   Total retinal thickness in the fovea (μm)   Thickness of neurosensory retina in the fovea (μm)   Thickness of SRD in the fovea (μm)   Foveal cystoid spaces   SRD at the fovea   Swelling of OPL   Cystoid spaces in OPL   Break on the external surface of retina   Hyper-reflective foci   Treatment   Final VA   Follow -up (months)
  --------- -------------------------- ------------------ ------------ ------------------------------------------- ---------------------------------------------------- ------------------------------------ ----------------------- ------------------ ----------------- ----------------------- ----------------------------------------- ----------------------- ----------- ---------- ---------------------
  1         58/F/R                     Inferior           0.5          490                                         231                                                  259                                  A                       P                  P                 P                       P                                         P                       PC          0.7        3
  2         63/F/L                     Superior           0.9          403                                         166                                                  237                                  A                       P                  P                 P                       A                                         P                       \-          1.5        24
  3         88/M/R                     Inferior           0.7          426                                         132                                                  294                                  A                       P                  P                 P                       A                                         P                       PC          0.7        13
  4         63/F/R                     Superior           0.7          415                                         323                                                  92                                   P                       P                  P                 P                       A                                         P                       PC          0.9        42
  5         62/M/L                     Superior           0.4          460                                         96                                                   364                                  A                       P                  P                 A                       A                                         P                       PC          0.6        6
  6         53/M/L                     Superior           0.3          254                                         126                                                  128                                  A                       P                  P                 A                       A                                         P                       \-          0.5        49
  7         53/M/R                     Superior           0.8          529                                         188                                                  341                                  A                       P                  P                 P                       A                                         P                       \-          1.5        4
  8         70/M/L                     Nasal              0.6          359                                         153                                                  206                                  A                       P                  P                 A                       A                                         A                       PC          0.2        37
  9         81/M/R                     Inferior           0.2          379                                         198                                                  181                                  A                       P                  P                 P                       P                                         A                       PC          0.3        4

**Note:** Visual acuity was measured on a Landolt chart.

**Abbreviations:** SD, standard deviation; F, female; M, male; R, right; L, left; VA, visual acuity; BRVO**,** branch retinal vein occlusion; A, absent; P, present; SRD, serous retinal detachment; OPL, outer plexiform layer; PC, laser photocoagulation.
